Article
Anti-Carbamylated Protein Antibody Identifies Seronegative Early Rheumatoid Arthritis Missed by Anti-CCP, Independently Predicts Joint Deformity, and Extends ACR/EULAR Classification: A Dose-Response and Bootstrap-Validated Cross-Sectional Study from North India
2026-06-02
Abstract excerpt
<title>Abstract</title> <p>Background Anti-cyclic citrullinated peptide (anti-CCP) antibodies miss 30–50% of early rheumatoid arthritis (RA) presentations, delaying treatment and permitting structural damage. Anti-carbamylated protein (anti-CarP) antibodies target homocitrullinated proteins via an HLA-DRB1 shared-epitope-independent pathway biochemically distinct from anti-CCP, making them candidates to fill thi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0197863c-c722-5bde-b509-4ae3868fc930
- DOI
- 10.21203/rs.3.rs-9782080/v1
